Diabetes hastens progression of preclinical heart failure
Author: Eleanor McDermid medwireNews: The presence of diabetes in people with preclinical heart failure (HF) shortens the time to a first clinical event, especially if blood glucose is poorly controlled, show data from the ARIC study. “Our results suggest that targeting diabetes early in the HF process is critical,” write Justin Echouffo-Tcheugui (Johns Hopkins University, […]
‘Reverse dipping’ forecasts long-term mortality in people with diabetes
Having blood pressure that is higher at night than during the day is associated with an increased mortality risk in people with diabetes, shows a 21-year study.
Researchers calculate unannounced snack threshold for closed-loop system
Author: Laura Cowen medwireNews: Children and adolescents using an advanced hybrid closed-loop system (a-HCL) for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report. Daniela Nisticò (University of Trieste) and colleagues say their findings “may be particularly helpful for children who are still not […]
Corticosteroid treatment and the consequences for glucose control
Author: John Wilding The clinical challenge Glucocorticoids, which include long-acting corticosteroid preparations such as prednisolone and dexamethasone, are frequently used to treat inflammatory conditions such as asthma and exacerbations of chronic obstructive pulmonary disease, and other conditions including many autoimmune diseases, and also to reduce cerebral edema in association with brain tumors. More recently, the […]
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
https://www.youtube.com/watch?v=-m2mdihaKmY Recorded: Monday, October 11, 2021Broadcast: Thursday, October 21, 2021 Meet the faculty Alice Cheng Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto. Lars Rydén (Chair) Lars Rydén is Senior Professor of Cardiology at the Karolinska Institute, Stockholm, Sweden. He is […]
Management of type 1 diabetes: ADA/EASD consensus report
Anne Peters talks about the goals of the ADA/EASD type 1 diabetes management consensus report, the issues to urgently address, and the joys of being part of a trans-Atlantic collaboration (9:53). 0:00 – The goals of the report0:53 – The importance of psychosocial care3:35 – Are providers ready for routine use of technology?4:30 – Type […]
TriMaster supports precision medicine strategy for type 2 diabetes treatment intensification
Author: Claire Barnard medwireNews: Findings from the TriMaster trial suggest that stratification of people with type 2 diabetes based on clinical features may help to guide the choice of second- or third-line drug for those who require treatment intensification after metformin. “This is the first trial to directly test and prove a stratified approach in […]
FIGARO: Where will finerenone fit into diabetic kidney disease treatment?
David Wheeler talks about the findings of the FIGARO trial, the use of finerenone in people with type 2 diabetes, and how this may fit with SGLT2 inhibitors (7:22).
DKD treatment update: SGLT2 inhibitors and finerenone
Nephrologist Ian de Boer joins primary care physician Amrit Lamba to discuss how the recent approval of finerenone and extension of the dapagliflozin label is likely to influence the treatment of kidney disease in people with type 2 diabetes. https://www.youtube.com/watch?v=S8KG0pW1xsY 0:00 Introduction 1:40 The DAPA-CKD trial: Building on CREDENCE 5:01 How the trial findings will influence primary care 7:10 Safety […]
Suicide in diabetes: An important but under-recorded problem
The FDA has recently highlighted the elevated risk for suicide in people with diabetes, resulting in the creation of the REducing SuiCide rates amongst individUals with diabEtes (RESCUE) Collaborative Community to examine issues relating to the identification and management of increased suicide risk in people with diabetes. In this brief overview, we look at the […]
